Tight glycemic control: Critical care's balancing act
In Vivo 03 September 2012 0:00
In
Vivo staff writer Mary Stuart provides an in-depth analysis of
the continuous blood glucose monitoring market, highlighting
GlySure and its technology. The article provides a detailed look at
GlySure's history, management team, core chemistry, funding,
clinical trials, and competitors.